Premium Nahrungsergänzungsmittel | artgerecht

Modified Release – Controlled Drug Release Explained

Modified release is a pharmaceutical technology that slows or controls the release of an active ingredient, maintaining a steady drug level in the blood over a longer period of time.

Regular tips about health Regular tips about health

Things worth knowing about "Modified Release"

Modified release is a pharmaceutical technology that slows or controls the release of an active ingredient, maintaining a steady drug level in the blood over a longer period of time.

What is Modified Release?

Modified release (also referred to as sustained release, extended release, or controlled release) is a pharmaceutical approach in which an active ingredient is not released immediately after ingestion, but rather gradually and in a controlled manner over an extended period. Medications formulated this way are commonly called modified-release tablets, extended-release capsules, or depot formulations. The primary goal is to maintain a stable and therapeutically effective drug concentration in the bloodstream throughout the day.

Mechanism of Action

Conventional (immediate-release) medications are absorbed quickly, causing a rapid peak in drug concentration followed by an equally rapid decline. Modified-release formulations prevent this pattern by slowing the rate at which the drug is made available for absorption. Several technologies are used to achieve this:

Matrix tablets: The active ingredient is embedded within a polymer matrix that gradually erodes or allows diffusion of the drug.
Membrane coating (film coating): A semi-permeable membrane surrounds the tablet or capsule, regulating drug passage into the gastrointestinal tract.
Osmotic systems (OROS): Osmotic pressure pushes the drug out of the tablet through a small laser-drilled hole at a controlled rate.
Pellets and microcapsules: The dose is divided into many small beads with varying release times, resulting in a smooth overall release profile.

Medical Applications

Modified-release formulations are used across a wide range of therapeutic areas, particularly where stable drug levels are critical for efficacy and safety:

Cardiology: Extended-release metoprolol or nifedipine for hypertension and heart conditions
Pain management: Modified-release morphine or tramadol for chronic pain
Psychiatry and neurology: Extended-release lithium, quetiapine, or methylphenidate
Diabetology: Extended-release metformin for type 2 diabetes
Urology: Extended-release tamsulosin for benign prostatic hyperplasia

Advantages of Modified Release

Compared to conventional immediate-release formulations, modified-release preparations offer several clinical benefits:

More stable blood drug levels, minimizing peaks and troughs that can cause side effects or loss of efficacy
Reduced dosing frequency (often once daily), improving patient adherence to therapy
Lower risk of side effects associated with high peak drug concentrations
Improved tolerability, especially for drugs with a narrow therapeutic window

Important Usage Notes

Modified-release tablets and capsules must generally not be split, crushed, or chewed, as doing so destroys the controlled-release mechanism and can lead to the entire dose being released at once. This may result in dangerous overdose effects. Any exceptions -- where splitting is permitted -- are clearly stated in the package leaflet or on the packaging.

Patients should always take modified-release medications as directed by their physician, maintaining consistent timing to ensure a steady therapeutic drug level.

Related Terms

Several related terms describe similar concepts in pharmaceutical science:

Sustained Release (SR): Uniform, ongoing drug release over an extended period
Extended Release (XR / ER): Prolonged drug release, commonly used in North American labeling
Controlled Release (CR): Release with a precisely defined pharmacokinetic profile
Depot injection: Injectable formulations in which the drug is slowly absorbed from a tissue reservoir (e.g., depot antipsychotics)

References

European Medicines Agency (EMA) - Guideline on quality of oral modified release products. EMA/CHMP/QWP/428693/2013 (2014). Available at: https://www.ema.europa.eu
Rang H.P., Dale M.M., Ritter J.M. et al. - Rang and Dale's Pharmacology. 9th ed. Elsevier, Edinburgh (2020).
Lachman L., Lieberman H.A., Kanig J.L. - The Theory and Practice of Industrial Pharmacy. 3rd ed. Lea and Febiger, Philadelphia (1986).

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.